{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T17:53:02Z","timestamp":1793555582626,"version":"4.5.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T00:00:00Z","timestamp":1288656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s12032-010-9730-x","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T15:44:17Z","timestamp":1288712657000},"page":"667-669","source":"Crossref","is-referenced-by-count":17,"title":["Bladder metastasis of malignant melanoma: a case report and review of literature"],"prefix":"10.1007","volume":"28","author":[{"given":"Ozan","family":"Efesoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selahittin","family":"Cayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,2]]},"reference":[{"key":"9730_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225\u201349.","journal-title":"CA Cancer J Clin"},{"key":"9730_CR2","first-page":"2732","volume-title":"Campbell\u2019s urology","author":"EM Messing","year":"2002","unstructured":"Messing EM. Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell\u2019s urology. 8th ed. Philadelphia: Saunders; 2002. p. 2732\u201384.","edition":"8"},{"key":"9730_CR3","doi-asserted-by":"crossref","first-page":"35xi","DOI":"10.1016\/S0090-4295(03)00156-0","volume":"62","author":"CS Lee","year":"2003","unstructured":"Lee CS, et al. Management of metastatic malignant melanoma of the bladder. Urology. 2003;62:35xi\u201335xiii.","journal-title":"Urology"},{"key":"9730_CR4","first-page":"1277","volume":"55","author":"V Menendez Lopez","year":"2002","unstructured":"Menendez Lopez V, Alvarez-Vijande Garcia R, Sole Arques M, Carretero Gonzalez P. Bladder metastasis of malignant melanoma: report of a case. Arch Esp Urol. 2002;55:1277\u20139.","journal-title":"Arch Esp Urol"},{"key":"9730_CR5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000030506","volume":"64","author":"O Demirkesen","year":"2000","unstructured":"Demirkesen O, Yaycioglu O, Uygun N, Demir G, Yalcin V. A case of metastatic malignant melanoma presenting with hematuria. Urol Int. 2000;64:118\u201320.","journal-title":"Urol Int"},{"key":"9730_CR6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0748-7983(05)80079-4","volume":"21","author":"P Arapantoni-Dadioti","year":"1995","unstructured":"Arapantoni-Dadioti P, Panayiotides J, Kalkandi P, Christodoulou C, Delides GS. Metastasis of malignant melanoma to a transitional cell carcinoma of the bladder. Eur J Surg Oncol. 1995;21:92\u20133.","journal-title":"Eur J Surg Oncol"},{"key":"9730_CR7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/oxfordjournals.bmb.a072982","volume":"51","author":"SM Lee","year":"1995","unstructured":"Lee SM, Betticher DC, Thatcher N. Melanoma: chemotherapy. Br Med Bull. 1995;51:609\u201330.","journal-title":"Br Med Bull"},{"key":"9730_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00008390-200102000-00009","volume":"1","author":"M Huncharek","year":"2001","unstructured":"Huncharek M, Caubet JF, McGarry R. Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials. Melanoma Res. 2001;1:75\u201381.","journal-title":"Melanoma Res"},{"key":"9730_CR9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/CJI.0b013e318177a4ba","volume":"31","author":"N Acquavella","year":"2008","unstructured":"Acquavella N, et al. Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer. J Immunother. 2008;31:569\u201376.","journal-title":"J Immunother"},{"key":"9730_CR10","first-page":"193","volume":"18","author":"A Barth","year":"1995","unstructured":"Barth A, Wanek LA, Morton DL. Prognostic factors in 1, 521 melanoma patients with distant metastases. J Am Coll Surg. 1995;18:193\u2013201.","journal-title":"J Am Coll Surg"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9730-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-010-9730-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9730-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T01:23:42Z","timestamp":1559784222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-010-9730-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,2]]},"references-count":10,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9730"],"URL":"https:\/\/doi.org\/10.1007\/s12032-010-9730-x","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,2]]}}}